For years, parents worried that Tamiflu might trigger seizures in children with the flu. A major new study from Vanderbilt Children's Hospital turns that fear on its head: the drug actually cuts the risk of serious neurological complications in half.
Researchers analyzed health records from nearly 700,000 children in Tennessee over four years. They found that flu itself — not the medication — was driving seizures, hallucinations, and other neuropsychiatric events. Among kids who actually had influenza, those given oseltamivir (Tamiflu's generic name) experienced roughly 50% fewer of these complications compared to untreated children with the flu.
"It's the influenza," says Dr. James Antoon, the study's lead investigator. The data is stark: children without the flu who took oseltamivir as a preventive showed no increased risk of neurological events at all. The virus, not the remedy, was the culprit all along.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxThis matters because the 2024-2025 flu season brought a spike in severe neurological complications in children — seizures, altered mental status, behavioral changes — leaving many families terrified and uncertain about treatment options. The American Academy of Pediatrics recommends antiviral drugs for high-risk children, but lingering doubts about safety have sometimes made parents hesitant.
The research, published in JAMA Neurology, examined 1,230 serious neuropsychiatric events across the four-year period. The pattern was consistent: flu infection correlated with complications; oseltamivir correlated with protection. "These flu treatments are safe and effective, especially when used early," emphasizes Dr. Carlos Grijalva, a senior author on the study.
What this means in practice: if your child gets the flu and a doctor recommends Tamiflu, the evidence now clearly supports that decision. The drug isn't creating the neurological risks parents feared — it's actually reducing them. That's a meaningful shift in the risk-benefit calculus families face when deciding how to treat a sick child.
